145 related articles for article (PubMed ID: 11016640)
1. CD99 engagement: an effective therapeutic strategy for Ewing tumors.
Scotlandi K; Baldini N; Cerisano V; Manara MC; Benini S; Serra M; Lollini PL; Nanni P; Nicoletti G; Bernard G; Bernard A; Picci P
Cancer Res; 2000 Sep; 60(18):5134-42. PubMed ID: 11016640
[TBL] [Abstract][Full Text] [Related]
2. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.
Sohn HW; Choi EY; Kim SH; Lee IS; Chung DH; Sung UA; Hwang DH; Cho SS; Jun BH; Jang JJ; Chi JG; Park SH
Am J Pathol; 1998 Dec; 153(6):1937-45. PubMed ID: 9846983
[TBL] [Abstract][Full Text] [Related]
3. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K
Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132
[TBL] [Abstract][Full Text] [Related]
4. Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma.
Scotlandi K; Perdichizzi S; Bernard G; Nicoletti G; Nanni P; Lollini PL; Curti A; Manara MC; Benini S; Bernard A; Picci P
Eur J Cancer; 2006 Jan; 42(1):91-6. PubMed ID: 16326096
[TBL] [Abstract][Full Text] [Related]
5. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
[TBL] [Abstract][Full Text] [Related]
6. Primary orbital extraskeletal ewing sarcoma.
Li T; Goldberg RA; Becker B; McCann J
Arch Ophthalmol; 2003 Jul; 121(7):1049-52. PubMed ID: 12860815
[No Abstract] [Full Text] [Related]
7. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion.
Hahn JH; Kim MK; Choi EY; Kim SH; Sohn HW; Ham DI; Chung DH; Kim TJ; Lee WJ; Park CK; Ree HJ; Park SH
J Immunol; 1997 Sep; 159(5):2250-8. PubMed ID: 9278313
[TBL] [Abstract][Full Text] [Related]
8. MIC2 detection in tumors of bone and adjacent soft tissues.
Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
[TBL] [Abstract][Full Text] [Related]
9. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
[TBL] [Abstract][Full Text] [Related]
10. Production, characterization, and functional analysis of newly established CD99 monoclonal antibodies MT99/1 and MT99/2.
Khunkaewla P; Chiampanichayakul S; Yasamut U; Pata S; Kasinrerk W
Hybridoma (Larchmt); 2007 Aug; 26(4):241-50. PubMed ID: 17725386
[TBL] [Abstract][Full Text] [Related]
11. Engagement of CD99 induces up-regulation of TCR and MHC class I and II molecules on the surface of human thymocytes.
Choi EY; Park WS; Jung KC; Kim SH; Kim YY; Lee WJ; Park SH
J Immunol; 1998 Jul; 161(2):749-54. PubMed ID: 9670951
[TBL] [Abstract][Full Text] [Related]
12. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis of immature thymocytes mediated by E2/CD99.
Bernard G; Breittmayer JP; de Matteis M; Trampont P; Hofman P; Senik A; Bernard A
J Immunol; 1997 Mar; 158(6):2543-50. PubMed ID: 9058785
[TBL] [Abstract][Full Text] [Related]
14. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.
Nanni P; Landuzzi L; Manara MC; Righi A; Nicoletti G; Cristalli C; Pasello M; Parra A; Carrabotta M; Ferracin M; Palladini A; Ianzano ML; Giusti V; Ruzzi F; Magnani M; Donati DM; Picci P; Lollini PL; Scotlandi K
Sci Rep; 2019 Aug; 9(1):12174. PubMed ID: 31434953
[TBL] [Abstract][Full Text] [Related]
15. [Ewing's sarcoma of the head and neck: a case report].
Velche-Haag B; Dehesdin D; Proust F; Marie JP; Andrieu-Guitrancourt J; Laquerriere A
Ann Otolaryngol Chir Cervicofac; 2002 Dec; 119(6):363-8. PubMed ID: 12527847
[TBL] [Abstract][Full Text] [Related]
16. Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.
Gellini M; Ascione A; Flego M; Mallano A; Dupuis ML; Zamboni S; Terrinoni M; D'Alessio V; Manara MC; Scotlandi K; Picci P; Cianfriglia M
Curr Pharm Biotechnol; 2013; 14(4):449-63. PubMed ID: 22335486
[TBL] [Abstract][Full Text] [Related]
17. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
[TBL] [Abstract][Full Text] [Related]
18. Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.
Garofalo C; Capristo M; Manara MC; Mancarella C; Landuzzi L; Belfiore A; Lollini PL; Picci P; Scotlandi K
PLoS One; 2013; 8(12):e83832. PubMed ID: 24391834
[TBL] [Abstract][Full Text] [Related]
19. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.
Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361
[TBL] [Abstract][Full Text] [Related]
20. Intramedullary Ewing's sarcoma of the spinal cord associated with hydrocephalus.
Jia L; Li G; You C; He M; Ye F
Neurol India; 2009; 57(6):828-9. PubMed ID: 20139532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
